Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: A randomized controlled trial

Psychological Medicine

Volumn 36, Issue 5, 2006, Pages 669-678

  Röhricht, Frank ^a   Priebe, Stefan ^b  

^a NEWHAM CENTRE FOR MENTAL HEALTH   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADJUVANT THERAPY; ADULT; ARTICLE; BLUNTED AFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; MALE; MOTOR RETARDATION; NEGATIVE SYNDROME; OUTPATIENT; PATIENT SATISFACTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BODY IMAGE; DEPERSONALIZATION; EGO; EXERCISE MOVEMENT TECHNIQUES; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; PSYCHOTHERAPY; PSYCHOTHERAPY, GROUP; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SPATIAL BEHAVIOR;

EID: 33645745926     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291706007161     Document Type: Article

References (42)

1. Andrews, G., Sanderson, K., Corry, J., Issakidis, C. & Lapsley, H. (2003). Cost-effectiveness of current and optimal treatment for schizophrenia. British Journal of Psychiatry 183, 427-435.
2. Arango, C., Buchanan, R. W., Kirkpatrick, B. & Carpenter, W. T. (2004). The deficit syndrome in schizophrenia: Implications for the treatment of negative symptoms. European Psychiatry 19, 21-26.
3. Atkins, M., Burgess, A., Bottomley, C. & Riccio, M. (1997). Chlorpromazine equivalents: A consensus of opinion for both clinical and research applications. Psychiatric Bulletin 21, 224-226.
4. BMA & RPSGB (2003). British National Formulary BNF 46. British Medical Association & Royal Pharmaceutical Society of Great Britain: London.
5. Bustillo, J., Lauriello, J., Horan, W. & Keith, S. (2001). The psychosocial treatment of schizophrenia: An update. American Journal of Psychiatry 158, 163-175.
6. Chakos, M., Lieberman, J., Hoffman, E., Bradford, D. & Sheitman, B. (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials. American Journal of Psychiatry 158, 518-526.
7. Cohen, J. (1992). A power primer. Psychological Bulletin 112, 155-159.
8. Darby, J. A. (1970). Alteration of some body image indexes in schizophrenia. Journal of Consulting and Clinical Psychology 35, 116-121.
9. Durham, R. C., Guthrie, M., Morton, R. V., Reid, D. A., Treliving, L. R., Fowler, D. & MacDonald, R. R. (2003). Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. British Journal of Psychiatry 182, 303-311.
10. Goertzel, V., May, P. R. A., Salkin, J. & Schoop, T. (1965). Body-ego technique: An approach to the schizophrenic patient. Journal of Nervous and Mental Disease 141, 53-60.
11. Guimon, J. (1997). The Body in Psychotherapy. Karger: Basel.
12. Kay, S. R., Fiszbein, A. & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
13. Krietsch, S. & Heuer, B. (1997). Movement Therapy with Schizophrenia Patients [in German]. Gustav Fischer: Lübeck, Stuttgart, Jena, Ulm.
14. Kuipers, E., Garety, P., Fowler, D., Dunn, G., Bebbington, P., Freeman, D. & Hadley, C. (1997). London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of the treatment phase. British Journal of Psychiatry 171, 319-327.
15. Leucht, S., Pitschel-Walz, G., Abraham, D. & Kissling, W. (1999). Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophrenia Research 35, 51-68.
16. Liddle, P. F. (2000). Descriptive clinical features of schizophrenia. In New Oxford Textbook of Psychiatry, vol. 1 (ed. M. G. Gelder, J. J. Lopez-Ibor and N. C. Andreasen), pp. 571-576. Oxford University Press: New York.
17. May, P. R. A., Wexler, M., Salkin, J. & Schoop, T. (1963). Nonverbal techniques in the re-establishment of body image and self identity - a preliminary report. Research Report 16, 68-82.
18. Möller, H. J. (2000). Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: Methodological issues and clinical consequences. World Journal of Biological Psychiatry 1, 75-91.
19. Nitsun, M., Stapleton, J. H. & Bender, M. P. (1974). Movement and drama therapy with long-stay schizophrenics. British Journal of Medical Psychology 47, 101-119.
20. Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Martindale, B., Orbach, G. & Morgan, C. (2002). Psychological treatments in schizophrenia: II. Meta-analysis of randomized controlled trials of social skills training and cognitive remediation. Psychological Medicine 32, 783-791.
21. Priebe, S. & Gruyters, T. (1993). The role of the helping alliance scale in psychiatric community care. Journal of Nervous and Mental Disease 181, 552-557.
22. Priebe, S., Gruyters, T., Heinze, M., Hoffmann, C. & Jäkel, A. (1995). Subjective criteria in psychiatric care - methods of assessment for research and routine care [in German]. Psychiatrische Praxis 22, 140-144.
23. Priebe, S., Huxley, P., Knight, S. & Evans, S. (1999). Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry 45, 7-12.
24. Priebe, S. & Röhricht, F. (2001). Specific body image pathology in schizophrenia. Psychiatry Research 101, 289-301.
25. Rector, N. A. & Beck, A. T. (2001). Cognitive behavioral therapy for schizophrenia: An empirical review. Journal of Nervous and Mental Disease 189, 278-287.
26. Rector, N. A., Seeman, M. V. & Segal, Z. V. (2003). Cognitive therapy for schizophrenia: A preliminary randomized controlled trial. Schizophrenia Research 63, 1-11.
27. Röhricht, F. (2000). Body-oriented Psychotherapy in Mental Illness. A Manual for Research and Practice [in German]. Hogrefe: Göttingen, Bern, Toronto, Seattle.
28. Röhricht, F. & Priebe, S. (2002). Do cenesthesias and body image aberration characterize a subgroup in schizophrenia? Acta Psychiatrica Scandinavica 105, 276-282.
29. Scharfetter, C. (1999). Schizophrenic ego disorders - argument for body-including therapy [in German]. Schweizer Archiv für Neurologie und Psychiatrie 150, 11-15.
30. Sensky, T., Turkington, D., Kingdon, D., Scott, J. L., Scott, J., Siddle, R., O'Caroll, M. & Barnes, T. R. (2000). A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry 57, 165-172.
31. Seruya, B. B. (1977). The effects of training on body-size estimation of schizophrenics [Dissertation]. Abstracts International 38, 1421.
32. Sheitman, B. B. & Lieberman, J. A. (1998). The natural history and pathophysiology of treatment resistant schizophrenia. Journal of Psychiatric Research 32, 143-150.
33. Simpson, G. M. & Angus, J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 45, 11-19.
34. Staunton, T. (2002). Body Psychotherapy. Brunner-Routledge: East Sussex.
35. Tarrier, N. (2005). Cognitive behaviour therapy for schizophrenia - a review of development, evidence and implementation. Psychotherapy Psychosomatics 74, 136-144.
36. Tarrier, N., Beckett, R., Harwood, S., Baker, A., Yusupoff, L. & Ugarteburu, I. (1993). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry 162, 524-532.
37. Tarrier, N., Kinney, C., McCarthy, E., Humphreys, L., Wittkowski, A. & Morris, J. (2000). Two-year follow-up of cognitive-behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology 68, 917-922.
38. Totton, N. (2003). Body Psychotherapy: An Introduction. Open University Press: Maidenhead-Philadelphia.
39. Trimble, M. R. (1997). Biological Psychiatry (2nd edn). Wiley: Chichester.
40. Turkington, D., Dudley, R., Warman, D. M. & Beck, A. T. (2004). Cognitive-behavioral therapy for schizophrenia: A review. Journal of Psychiatric Practice 10, 5-16.
41. Valmaggia, L. R., van der Gaag, M., Tarrier, N., Pijnenborg, M. & Slooff, C. J. (2005). Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry 186, 324-330.
42. Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J. P., Citrome, L., McEvoy, J. P., Cooper, T. B., Chakos, M. & Lieberman, J. A. (2002). Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. American Journal of Psychiatry 159, 255-262.